ZC3HAV1(2-624)-p-BRAF(439-766) fusion [cytosol]

Stable Identifier
R-HSA-6802557
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
25204415 The landscape of kinase fusions in cancer

Stransky, N, Cerami, E, Schalm, S, Kim, JL, Lengauer, C

Nat Commun 2014
Participates
Other forms of this molecule
Modified Residues
Name
Insertion of residues 439 to 766 at 625 from UniProt:P15056 BRAF
Coordinate
625
Name
O-phospho-L-serine at 446
Coordinate
446
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Name
O-phospho-L-serine at 729
Coordinate
729
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Name
O-phospho-L-threonine at 599
Coordinate
599
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-threonine residue to O-phospho-L-threonine.
Name
O-phospho-L-serine at 602
Coordinate
602
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Disease
Name Identifier Synonyms
thyroid carcinoma DOID:3963 head and neck cancer, Thyroid
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Interactors (11)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P67809 YBX1  5 0.564 4
 UniProt:Q9NQT4 EXOSC5  3 0.536 2
 UniProt:Q9H9Z2 LIN28A  1 0.527 3
 UniProt:Q15646 OASL  1 0.527 2
 UniProt:P03372 ESR1  10 0.527 3
 UniProt:O95786 RIGI  4 0.524 3
 UniProt:Q12906 ILF3  3 0.483 2
 UniProt:Q9NR30 DDX21  1 0.483 2
 UniProt:P13569 CFTR  17 0.483 8
 UniProt:P62753 RPS6  4 0.483 4
 UniProt:Q8WYQ5 DGCR8  1 0.483 3
Cite Us!